Academia | Clutch Group

News & Insights

FCA publishes observations on the effectiveness of firms’ surveillance operations under the Suspicious Transaction Reporting (STR) regime

May 9th, 2016

The FCA has released another issue (no. 50) of Market Watch, its newsletter on market conduct and transaction reporting issues. There is some prominent commentary on surveillance operations used by firms to identify potential incidents of market abuse.  The FCA has conducted a program of visits to firms over the last […]

Read More >

Fed Official Advocates Breaking Up Banks

February 24th, 2016

Fed Official Advocates Breaking Up Banks   Recurring Theme:  Changing Regulatory Tide   Summary Analysis:  Neel Kashkari, President of the Federal Reserve Bank of Minneapolis, delivered remarks before the Brookings Institute in Washington, DC, last week.  During his remarks, Kashkari proposed breaking up the country’s largest banks to put an […]

Read More >

EU Regulators Invite Comment on AML Regulations

December 14th, 2015

  Rob Gruppetta, Head of Financial Crime at the United Kingdom’s (UK) Financial Conduct Authority (FCA), delivered remarks at the Accuity Anti-Money Laundering (AML) Risk Reduction and Compliance Europe Conference this week on December 8, 2015. The speech, entitled Examining the Future of AML Regulations, surveyed the current AML landscape […]

Read More >

International Privacy Conference Offers Platform to Discuss EU US Safe Harbor Ruling

October 26th, 2015

The International Privacy Conference convenes its 37th annual event today, October 26, 2015 through October 29, 2015, in Amsterdam.  Over 100 data protection and privacy commissioners representing 63 countries, including the European Union (EU), are expected to attend.  At the conference, a commission of nineteen “renowned privacy experts” from the […]

Read More >

Yale Study Calls for More Rigor Around Medical Device Testing

August 26th, 2015

Last week, Yale University’s School of Medicine’s Journal, The Journal of the American Medical Association, published a new study examining the testing process for high-risk medical devices.  Specifically, the study compared the number of premarket and postmarket clinical studies conducted by the Food and Drug Administration (FDA) as part of […]

Read More >